About UltraSight
UltraSight is a company based in Rehovot (Israel) founded in 2018 by Itay Kezurer, Achi Ludomirsky, and Yaron Lipman. UltraSight has raised $14.09 million across 2 funding rounds from investors including Weizmann Institute of Science, SELVAS Healthcare and Atain Insurance Companies. UltraSight offers products and services including AI Guidance Software. UltraSight operates in a competitive market with competitors including Qure.ai, Subtle Medical, Perspectum, Circle Cardiovascular Imaging and Zebra Medical Vision, among others.
- Headquarter Rehovot, Israel
- Founders Itay Kezurer, Achi Ludomirsky, Yaron Lipman
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.09 M (USD)
in 2 rounds
-
Latest Funding Round
$1.09 M (USD), Series B
Jun 11, 2023
-
Investors
Weizmann Institute of Science
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of UltraSight
UltraSight offers a comprehensive portfolio of products and services, including AI Guidance Software.
Provides real-time guidance for cardiac ultrasound in healthcare settings.
People of UltraSight
Unlock access to complete
Unlock access to complete
Funding Insights of UltraSight
UltraSight has successfully raised a total of $14.09M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $1.09 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in UltraSight
UltraSight has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Weizmann Institute of Science, SELVAS Healthcare and Atain Insurance Companies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Science courses and degrees are offered by the institute.
|
Locked | Locked | Locked | |
|
Property and casualty insurance is provided by Atain Insurance Companies.
|
Locked | Locked | Locked | |
|
Venture capital investments are directed toward multiple sectors.
|
Locked | Locked | Locked |
Investor details for UltraSight
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UltraSight
Investment portfolio details for UltraSight
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - UltraSight
Detailed financials for UltraSight
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ultrasight Comparisons
Peer comparison for UltraSight
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of UltraSight
UltraSight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qure.ai, Subtle Medical, Perspectum, Circle Cardiovascular Imaging and Zebra Medical Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
Software for cardiac MR and CT image evaluation is provided.
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| Locked | Locked | Locked |
Provide contract research imaging services and software
|
Detailed competitors of UltraSight
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ultrasight
Complete news archive for UltraSight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UltraSight
UltraSight was founded in 2018 and raised its 1st funding round 3 years after it was founded.
UltraSight is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
UltraSight is a funded company, having raised a total of $14.09M across 2 funding rounds to date.
UltraSight was founded in 2018 in Rehovot, Israel, within the health technology sector focused on AI-driven medical imaging. An AI-based platform is provided for ultrasound diagnosis of cardiac disorders, enabling clinical decision support through cardiac imaging and sonography. The software is designed to integrate with ultrasound devices for analysis and diagnostic purposes, supporting healthcare professionals in routine examinations.
UltraSight's top competitors include Perspectum, Qure.ai and Subtle Medical.
UltraSight offers AI Guidance Software.
UltraSight has 4 investors. Key investors include Weizmann Institute of Science, SELVAS Healthcare, Atain Insurance Companies, and Yozma Group Korea.